PMID- 20335639 OWN - NLM STAT- MEDLINE DCOM- 20101027 LR - 20211020 IS - 1529-7268 (Electronic) IS - 0006-3363 (Print) IS - 0006-3363 (Linking) VI - 83 IP - 1 DP - 2010 Jul TI - Human pregnancy specific beta-1-glycoprotein 1 (PSG1) has a potential role in placental vascular morphogenesis. PG - 27-35 LID - 10.1095/biolreprod.109.082412 [doi] AB - Previous studies suggest that human pregnancy specific beta-1-glycoproteins (PSGs) play immunomodulatory roles during pregnancy; however, other possible functions of PSGs have yet to be explored. We have observed that PSGs induce transforming growth factor beta 1 (TGFB1), which among its other diverse functions inhibits T-cell function and has proangiogenic properties. The present study investigates a potential role for PSG1, the most abundant PSG in maternal serum, as a possible inducer of proangiogenic growth factors known to play an important role in establishment of the vasculature at the maternal-fetal interface. To this end, we measured TGFB1, vascular endothelial growth factors (VEGFs) A and C, and placental growth factor (PGF) protein levels in several cell types after PSG1 treatment. In addition, tube formation and wound healing assays were performed to investigate a possible direct interaction between PSG1 and endothelial cells. PSG1 induced up-regulation of both TGFB1 and VEGFA in human monocytes, macrophages, and two human extravillous trophoblast cell lines. We did not observe induction of VEGFC or PGF by PSG1 in any of the cells tested. PSG1 treatment resulted in endothelial tube formation in the presence and absence of VEGFA. Site-directed mutagenesis was performed to map the essential regions within the N-domain of PSG1 required for functional activity. We found that the aspartic acid at position 95, previously believed to be required for binding of PSGs to cells, is not required for PSG1 activity but that the amino acids implicated in the formation of a salt bridge within the N-domain are essential for PSG1 function. FAU - Ha, Cam T AU - Ha CT AD - Department of Pathology, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, USA. FAU - Wu, Julie A AU - Wu JA FAU - Irmak, Ster AU - Irmak S FAU - Lisboa, Felipe A AU - Lisboa FA FAU - Dizon, Anne M AU - Dizon AM FAU - Warren, James W AU - Warren JW FAU - Ergun, Suleyman AU - Ergun S FAU - Dveksler, Gabriela S AU - Dveksler GS LA - eng GR - R01 HD 035832/HD/NICHD NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural DEP - 20100324 PL - United States TA - Biol Reprod JT - Biology of reproduction JID - 0207224 RN - 0 (PGF protein, human) RN - 0 (Pregnancy Proteins) RN - 0 (Pregnancy-Specific beta 1-Glycoproteins) RN - 0 (Recombinant Proteins) RN - 0 (TGFB1 protein, human) RN - 0 (Transforming Growth Factor beta1) RN - 0 (VEGFA protein, human) RN - 0 (Vascular Endothelial Growth Factor A) RN - 144589-93-5 (Placenta Growth Factor) SB - IM MH - Endothelial Cells/metabolism MH - Female MH - Humans MH - Macrophages/metabolism MH - Mutagenesis, Site-Directed MH - *Neovascularization, Physiologic MH - Placenta/blood supply/*metabolism MH - Placenta Growth Factor MH - Placentation MH - Pregnancy MH - Pregnancy Proteins/metabolism MH - Pregnancy-Specific beta 1-Glycoproteins/genetics/*metabolism MH - Recombinant Proteins/metabolism MH - Transforming Growth Factor beta1/*metabolism MH - Trophoblasts/metabolism MH - Vascular Endothelial Growth Factor A/*metabolism PMC - PMC2888962 EDAT- 2010/03/26 06:00 MHDA- 2010/10/28 06:00 PMCR- 2010/07/01 CRDT- 2010/03/26 06:00 PHST- 2010/03/26 06:00 [entrez] PHST- 2010/03/26 06:00 [pubmed] PHST- 2010/10/28 06:00 [medline] PHST- 2010/07/01 00:00 [pmc-release] AID - biolreprod.109.082412 [pii] AID - 10.1095/biolreprod.109.082412 [doi] PST - ppublish SO - Biol Reprod. 2010 Jul;83(1):27-35. doi: 10.1095/biolreprod.109.082412. Epub 2010 Mar 24.